Cigna (CI) Stock
Major US health insurer with pharmacy and care services. Here's the price, business snapshot, and what's worth knowing about Cigna in October 2026.
Cigna Corporation (CI) is a large, US‑based health‑care and services company combining traditional health insurance with pharmacy and care‑management services through its Evernorth business. Its revenue mix includes employer and individual medical plans, Medicare products, and pharmacy benefit management and care solutions. Investors typically watch member trends, medical cost inflation, price negotiations with providers and drug‑pricing dynamics — all of which can move margins and earnings. Cigna’s business is sensitive to regulation, reimbursement changes and economic cycles that affect employer-sponsored coverage. With a market capitalisation of about $82.08 billion, it’s considered a major industry participant, but not immune to competition from insurers, PBMs and new entrants. This summary is general educational information, not personalised financial advice. Investors should consider their own circumstances, risk tolerance and seek regulated advice if needed; values can fall as well as rise and past performance is not a guide to future results.
Why It’s Moving
Cigna Unveils $3 Billion AI-Driven Modernization Plan and Reaffirms 2026 Outlook at Investor Day
- Cigna announced a $3 billion investment in a multi-year program focused on modernizing processes and streamlining workflows using AI-enabled insights and tools.
- The company introduced the 'Lead to One' vision, aiming to unify colleagues around delivering personalization at scale to improve affordability and patient experience within the health care continuum.
- Management reaffirmed 2026 full-year financial guidance and outlined a long-term target of 10-14% adjusted EPS compound annual growth rate through 2030.
Cigna Unveils $3 Billion AI-Driven Modernization Plan and Reaffirms 2026 Outlook at Investor Day
- Cigna announced a $3 billion investment in a multi-year program focused on modernizing processes and streamlining workflows using AI-enabled insights and tools.
- The company introduced the 'Lead to One' vision, aiming to unify colleagues around delivering personalization at scale to improve affordability and patient experience within the health care continuum.
- Management reaffirmed 2026 full-year financial guidance and outlined a long-term target of 10-14% adjusted EPS compound annual growth rate through 2030.
Sixth Month Growth Performance
When is the next earnings date for Cigna Corp (CI)?
The next earnings date for CI has not been confirmed yet. Based on the company's historical reporting pattern, which typically follows a quarterly cycle of approximately three months after the previous report, the expected timing is Q3 2026. Investors should anticipate this release in late October or early November 2026.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Cigna's stock, predicting it could rise significantly in value.
Financial Health
Cigna Corp is generating strong revenue and cash flow, indicating a healthy financial position.
Dividend
Cigna's dividend yield of 2.29% offers moderate income potential for investors seeking dividends. If you invested $1000 you would be paid $22.90 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Pharmacy & care growth
Evernorth’s pharmacy and care‑management services can drive revenue diversification and margin enhancement, though execution and pricing pressure matter.
US‑focused footprint
Cigna’s operations are primarily US‑centred, so domestic regulation and employer benefits trends heavily influence results; global shocks can still have indirect effects.
Regulation and margins
Policy shifts, reimbursement rates and drug pricing reforms can materially affect profitability — investors should factor regulatory risk into valuations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
